Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Cyclin-Dependent Kinases

Items 31-40 of 65

Page
per page
  1. GX-674
    A8718 GX-674
    Target: Voltage-gated Sodium (NaV) Channels
    Summary: Nav1.7 antagonist
      Soluble in DMSO
  2. THZ2
    A8717 THZ2
     1 Citation
    Target: Cyclin-Dependent Kinases
    Summary: CDK7 inhibitor
      ≥28.3 mg/mL
  3. WHI-P180
    A8643 WHI-P180
    Summary: EGFR/Janus Kinase 3 inhibitor
      Soluble in DMSO
  4. R547
    A8642 R547
     2 Citation
    Target: Cyclin-Dependent Kinases
    Summary: CDK1/2/4 inhibitor,ATP-competitive
      Soluble in DMSO
  5. LEE011
    A8641 LEE011
    Target: Cyclin-Dependent Kinases
    Summary: CDK4/6 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥10.88 mg/mL
  6. Flavopiridol hydrochloride
    A8640 Flavopiridol hydrochloride
    Summary: CDK inhibitor, potent and selective
      ≥21.9 mg/mL
  7. Deferasirox
    A8639 Deferasirox
     3 Citation
    Summary: Oral iron chelator
      insoluble in H2O; ≥37.28 mg/mL
  8. Purvalanol B
    A8565 Purvalanol B
     1 Citation
    Target: Cyclin-Dependent Kinases
    Summary: CDK1/CDK2/CDK4 inhibitor
      ≥21.65 mg/mL
  9. PHA-848125
    A8501 PHA-848125
    Target: Cyclin-Dependent Kinases
    Summary: CDK inhibitor,potent and ATP-competitive
      ≥23.05 mg/mL
  10. Dinaciclib (SCH727965)
    A8412 Dinaciclib (SCH727965)
     5 Citation
    Target: Cyclin-Dependent Kinases
    Summary: Potent CDK inhibitor

Items 31-40 of 65

Page
per page